Bicycle Therapeutics is a clinical-stage biopharmaceutical enterprise dedicated to discovering and developing an entirely new class of targeted therapeutics known as bicyclic peptides (Bicycles). Operating squarely within the biotechnology sector, the company combines the traditional pharmacology of small-molecule drugs with the target specificity of antibodies to create innovative treatments for oncology and severe immunological diseases.